These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 21425139)

  • 1. Phosphorylated AKT expression is associated with PIK3CA mutation, low stage, and favorable outcome in 717 colorectal cancers.
    Baba Y; Nosho K; Shima K; Hayashi M; Meyerhardt JA; Chan AT; Giovannucci E; Fuchs CS; Ogino S
    Cancer; 2011 Apr; 117(7):1399-408. PubMed ID: 21425139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SMO expression in colorectal cancer: associations with clinical, pathological, and molecular features.
    Li T; Liao X; Lochhead P; Morikawa T; Yamauchi M; Nishihara R; Inamura K; Kim SA; Mima K; Sukawa Y; Kuchiba A; Imamura Y; Baba Y; Shima K; Meyerhardt JA; Chan AT; Fuchs CS; Ogino S; Qian ZR
    Ann Surg Oncol; 2014 Dec; 21(13):4164-73. PubMed ID: 25023548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGFBR2 and BAX mononucleotide tract mutations, microsatellite instability, and prognosis in 1072 colorectal cancers.
    Shima K; Morikawa T; Yamauchi M; Kuchiba A; Imamura Y; Liao X; Meyerhardt JA; Fuchs CS; Ogino S
    PLoS One; 2011; 6(9):e25062. PubMed ID: 21949851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D receptor expression is associated with PIK3CA and KRAS mutations in colorectal cancer.
    Kure S; Nosho K; Baba Y; Irahara N; Shima K; Ng K; Meyerhardt JA; Giovannucci EL; Fuchs CS; Ogino S
    Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2765-72. PubMed ID: 19789368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDK8 expression in 470 colorectal cancers in relation to beta-catenin activation, other molecular alterations and patient survival.
    Firestein R; Shima K; Nosho K; Irahara N; Baba Y; Bojarski E; Giovannucci EL; Hahn WC; Fuchs CS; Ogino S
    Int J Cancer; 2010 Jun; 126(12):2863-73. PubMed ID: 19790197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival.
    Liao X; Lochhead P; Nishihara R; Morikawa T; Kuchiba A; Yamauchi M; Imamura Y; Qian ZR; Baba Y; Shima K; Sun R; Nosho K; Meyerhardt JA; Giovannucci E; Fuchs CS; Chan AT; Ogino S
    N Engl J Med; 2012 Oct; 367(17):1596-606. PubMed ID: 23094721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer.
    Baba Y; Nosho K; Shima K; Meyerhardt JA; Chan AT; Engelman JA; Cantley LC; Loda M; Giovannucci E; Fuchs CS; Ogino S
    Br J Cancer; 2010 Sep; 103(7):1025-33. PubMed ID: 20808308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis.
    Mima K; Nishihara R; Qian ZR; Cao Y; Sukawa Y; Nowak JA; Yang J; Dou R; Masugi Y; Song M; Kostic AD; Giannakis M; Bullman S; Milner DA; Baba H; Giovannucci EL; Garraway LA; Freeman GJ; Dranoff G; Garrett WS; Huttenhower C; Meyerson M; Meyerhardt JA; Chan AT; Fuchs CS; Ogino S
    Gut; 2016 Dec; 65(12):1973-1980. PubMed ID: 26311717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic role of PIK3CA mutation in colorectal cancer: cohort study and literature review.
    Liao X; Morikawa T; Lochhead P; Imamura Y; Kuchiba A; Yamauchi M; Nosho K; Qian ZR; Nishihara R; Meyerhardt JA; Fuchs CS; Ogino S
    Clin Cancer Res; 2012 Apr; 18(8):2257-68. PubMed ID: 22357840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIK3CA mutation is associated with poor prognosis among patients with curatively resected colon cancer.
    Ogino S; Nosho K; Kirkner GJ; Shima K; Irahara N; Kure S; Chan AT; Engelman JA; Kraft P; Cantley LC; Giovannucci EL; Fuchs CS
    J Clin Oncol; 2009 Mar; 27(9):1477-84. PubMed ID: 19237633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor TP53 expression status, body mass index and prognosis in colorectal cancer.
    Morikawa T; Kuchiba A; Liao X; Imamura Y; Yamauchi M; Qian ZR; Nishihara R; Sato K; Meyerhardt JA; Fuchs CS; Ogino S
    Int J Cancer; 2012 Sep; 131(5):1169-78. PubMed ID: 22038927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTGER2 overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.
    Baba Y; Nosho K; Shima K; Goessling W; Chan AT; Ng K; Chan JA; Giovannucci EL; Fuchs CS; Ogino S
    Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):822-31. PubMed ID: 20200425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PIK3CA and PTEN gene and exon mutation-specific clinicopathologic and molecular associations in colorectal cancer.
    Day FL; Jorissen RN; Lipton L; Mouradov D; Sakthianandeswaren A; Christie M; Li S; Tsui C; Tie J; Desai J; Xu ZZ; Molloy P; Whitehall V; Leggett BA; Jones IT; McLaughlin S; Ward RL; Hawkins NJ; Ruszkiewicz AR; Moore J; Busam D; Zhao Q; Strausberg RL; Gibbs P; Sieber OM
    Clin Cancer Res; 2013 Jun; 19(12):3285-96. PubMed ID: 23633456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MGMT promoter methylation, loss of expression and prognosis in 855 colorectal cancers.
    Shima K; Morikawa T; Baba Y; Nosho K; Suzuki M; Yamauchi M; Hayashi M; Giovannucci E; Fuchs CS; Ogino S
    Cancer Causes Control; 2011 Feb; 22(2):301-9. PubMed ID: 21140203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cohort study of STMN1 expression in colorectal cancer: body mass index and prognosis.
    Ogino S; Nosho K; Baba Y; Kure S; Shima K; Irahara N; Toyoda S; Chen L; Kirkner GJ; Wolpin BM; Chan AT; Giovannucci EL; Fuchs CS
    Am J Gastroenterol; 2009 Aug; 104(8):2047-56. PubMed ID: 19513025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PIK3CA mutation in colorectal cancer: relationship with genetic and epigenetic alterations.
    Nosho K; Kawasaki T; Ohnishi M; Suemoto Y; Kirkner GJ; Zepf D; Yan L; Longtine JA; Fuchs CS; Ogino S
    Neoplasia; 2008 Jun; 10(6):534-41. PubMed ID: 18516290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor LINE-1 methylation level and microsatellite instability in relation to colorectal cancer prognosis.
    Inamura K; Yamauchi M; Nishihara R; Lochhead P; Qian ZR; Kuchiba A; Kim SA; Mima K; Sukawa Y; Jung S; Zhang X; Wu K; Cho E; Chan AT; Meyerhardt JA; Harris CC; Fuchs CS; Ogino S
    J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25190725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT3 expression, molecular features, inflammation patterns, and prognosis in a database of 724 colorectal cancers.
    Morikawa T; Baba Y; Yamauchi M; Kuchiba A; Nosho K; Shima K; Tanaka N; Huttenhower C; Frank DA; Fuchs CS; Ogino S
    Clin Cancer Res; 2011 Mar; 17(6):1452-62. PubMed ID: 21310826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective cohort study shows unique epigenetic, genetic, and prognostic features of synchronous colorectal cancers.
    Nosho K; Kure S; Irahara N; Shima K; Baba Y; Spiegelman D; Meyerhardt JA; Giovannucci EL; Fuchs CS; Ogino S
    Gastroenterology; 2009 Nov; 137(5):1609-20.e1-3. PubMed ID: 19686742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer.
    Lochhead P; Imamura Y; Morikawa T; Kuchiba A; Yamauchi M; Liao X; Qian ZR; Nishihara R; Wu K; Meyerhardt JA; Fuchs CS; Ogino S
    Eur J Cancer; 2012 Dec; 48(18):3405-13. PubMed ID: 22840368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.